The Ensign Group (NASDAQ:ENSG) had its target price upped by Truist Securities from $90.00 to $98.00 in a report published on Wednesday, Price Targets.com reports. They currently have a hold rating on the stock.
A number of other brokerages have also weighed in on ENSG. Truist lifted their price objective on shares of The Ensign Group from $64.00 to $82.00 in a report on Tuesday, January 5th. Royal Bank of Canada lifted their price objective on shares of The Ensign Group from $91.00 to $95.00 and gave the company an outperform rating in a report on Monday, March 22nd. Two analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of Buy and a consensus target price of $78.38.
ENSG stock opened at $92.07 on Wednesday. The Ensign Group has a 12 month low of $33.72 and a 12 month high of $98.66. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 0.15. The company has a 50-day moving average price of $89.42 and a 200 day moving average price of $76.81. The stock has a market cap of $5.04 billion, a PE ratio of 33.85, a P/E/G ratio of 1.73 and a beta of 1.05.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 30th. Stockholders of record on Wednesday, March 31st will be issued a $0.0525 dividend. The ex-dividend date is Tuesday, March 30th. This represents a $0.21 annualized dividend and a dividend yield of 0.23%. The Ensign Group’s dividend payout ratio is currently 10.05%.
In other news, Director Lee A. Daniels sold 983 shares of the business’s stock in a transaction dated Wednesday, January 20th. The shares were sold at an average price of $85.37, for a total value of $83,918.71. Following the completion of the sale, the director now owns 42,879 shares in the company, valued at approximately $3,660,580.23. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Daren Shaw sold 875 shares of the business’s stock in a transaction dated Monday, January 25th. The shares were sold at an average price of $85.19, for a total transaction of $74,541.25. Following the completion of the sale, the director now owns 43,000 shares of the company’s stock, valued at approximately $3,663,170. The disclosure for this sale can be found here. In the last 90 days, insiders sold 27,797 shares of company stock valued at $2,530,299. Company insiders own 6.80% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the stock. NEXT Financial Group Inc raised its stake in shares of The Ensign Group by 4,977.1% during the 1st quarter. NEXT Financial Group Inc now owns 2,437 shares of the company’s stock worth $229,000 after acquiring an additional 2,389 shares in the last quarter. Crossmark Global Holdings Inc. raised its stake in shares of The Ensign Group by 1.9% during the 1st quarter. Crossmark Global Holdings Inc. now owns 9,690 shares of the company’s stock worth $909,000 after acquiring an additional 180 shares in the last quarter. Brendel Financial Advisors LLC bought a new position in shares of The Ensign Group during the 1st quarter worth approximately $2,666,000. Everence Capital Management Inc. purchased a new stake in The Ensign Group during the 1st quarter worth approximately $752,000. Finally, Legacy Wealth Asset Management LLC purchased a new stake in The Ensign Group during the 4th quarter worth approximately $616,000. Hedge funds and other institutional investors own 78.63% of the company’s stock.
About The Ensign Group
The Ensign Group, Inc provides health care services in the post-acute care continuum and other ancillary businesses. It operates in two segments, Transitional and Skilled Services and Real Estate. The company offers transitional and skilled services, which include short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly; and physical, occupational, and speech therapies and other rehabilitative and healthcare services.
Recommended Story: What is a price target?
Receive News & Ratings for The Ensign Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Ensign Group and related companies with MarketBeat.com's FREE daily email newsletter.